Health Partners Inc
Minneapolis, Minnesota, United States
Non-profit organization in Minneapolis, Minnesota
4732 Chicago Ave, Minneapolis, MN 55407
About Health Partners Inc
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
National Cancer Institute (NCI)
97
SWOG Cancer Research Network
38
Alliance for Clinical Trials in Oncology
34
ECOG-ACRIN Cancer Research Group
18
NRG Oncology
10
Wake Forest University Health Sciences
8
GOG Foundation
4
University of Rochester NCORP Research Base
4
HealthPartners Institute
3
Eastern Cooperative Oncology Group
2
Gynecologic Oncology Group
2
Clinical Trials at Health Partners Inc
During the past decade, Health Partners Inc conducted 157 clinical trials. In the 10-year time frame, 157 clinical trials started and 73 clinical trials were completed, i.e. on
average, 46.5% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 50 clinical trials were completed. i.e. 131.6%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Radiation Therapy With or Without Cisplatin in Treating Patients With Recurrent Endometrial Cancer
2008-02-25
Active, not recruiting
165
Carboplatin, Paclitaxel and Gemcitabine Hydrochloride With or Without Bevacizumab After Surgery in Treating Patients With Recurrent Ovarian, Epithelial, Primary Peritoneal, or Fallopian Tube Cancer
2007-12-06
Active, not recruiting
1,052
Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
2008-08-08
Active, not recruiting
403
Radiation Therapy Regimens in Treating Patients With Limited-Stage Small Cell Lung Cancer Receiving Cisplatin and Etoposide
2008-03-01
Active, not recruiting
731
Diet and Physical Activity Change or Usual Care in Improving Progression-Free Survival in Patients With Previously Treated Stage II, III, or IV Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
2012-06-18
Unknown status
1,070
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
2008-11-10
Active, not recruiting
2,014
Lenalidomide With or Without Epoetin Alfa in Treating Patients With Myelodysplastic Syndrome and Anemia
2009-01-29
2023-09-21
Active, not recruiting
247
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Health Partners Inc" #1 sponsor was "National Cancer Institute (NCI)" with 97 trials, followed by "SWOG Cancer Research Network" with 38 trials
sponsored, "Alliance for Clinical Trials in Oncology" with 34 trials sponsored, "ECOG-ACRIN Cancer Research Group" with 18 trials sponsored and "NRG Oncology"
with 18 trials sponsored. Other sponsors include 22 different institutions and
companies that sponsored additional 15 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Health Partners Inc"
#1 collaborator was "National Cancer Institute (NCI)" with 120 trials as a collaborator, "NRG Oncology" with 18 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "Astellas Pharma US, Inc." with 2 trials as a collaborator and "Genentech, Inc." with 2 trials as a collaborator. Other collaborators include 26 different institutions and companies that were
collaborators in the rest 35 trials.
Clinical Trials Conditions at Health Partners Inc
According to Clinical.Site data, the most researched conditions in "Health Partners Inc" are
"Invasive Breast Carcinoma" (10 trials), "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Lung Cancer AJCC v8" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials) and "Recurrent Ovarian Carcinoma" (7 trials). Many other conditions were trialed in "Health Partners Inc" in a lesser frequency.
Clinical Trials Intervention Types at Health Partners Inc
Most popular intervention types in "Health Partners Inc" are "Drug" (165 trials), "Other" (139 trials), "Biological" (85 trials), "Procedure" (61 trials) and "Radiation" (25 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (63 trials), "Quality-of-Life Assessment" (61 trials), "Questionnaire Administration" (38 trials), "Biospecimen Collection" (31 trials) and "Computed Tomography" (31 trials). Other intervention names were less common.
Clinical Trials Genders at Health Partners Inc
The vast majority of trials in "Health Partners Inc" are
184 trials for "All" genders, 34 trials for "Female" genders and 6 trials for "Male" genders.
Clinical Trials Status at Health Partners Inc
Currently, there are NaN active trials in "Health Partners Inc".
undefined are not yet recruiting,
66 are recruiting,
104 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 40 completed trials in Health Partners Inc,
7 suspended trials,
and 5 terminated clinical trials to date.
Out of the total trials that were conducted in Health Partners Inc, 3 "Phase 1"
clinical trials were conducted, 109 "Phase 2" clinical
trials and 102 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 14 trials that are defined as “Not Applicable".